We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Boston Partners, founded in 1995, manages about $127 billion in assets as of Dec. 31, 2025. Its mutual funds cover U.S., global, and non-U.S. equities. The investment strategy employs the three-circle method to choose stocks by evaluating their value, business fundamentals and market trend performance. ESG factors are included in its investment process, making the funds a structured investment option.
We have chosen two Boston Partnersmutual funds —Boston Partners Long/Short Equity Inv ((BPLEX - Free Report) ) and Boston Partners Small Cap Value II Inv ((BPSCX - Free Report) )— that investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Boston Partners Long/Short Equity Inv fund seeks long-term capital appreciation while minimizing exposure to general equity market risk. BPLEX invests in equity securities.
Patrick Regan has been the lead manager of BPLEX since Jan. 1, 2019. Most of the fund's holdings were in companies like Fairfax Financial Holdings Ltd (2.1%), Alphabet Inc. (2%) and British American Tobacco p.l.c. (1.9%) as of Aug. 31, 2025.
BPLEX's 3-year and 5-year annualized returns are 18.5% and 18.5%, respectively. Its net expense ratio is 2.21%. BPLEX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds please click here.
Boston Partners Small Cap Value II Inv fund seeks to provide long-term growth of capital primarily through investment in equity securities. BPSCX invests its net assets in a diversified portfolio consisting primarily of equity securities with market capitalizations that do not exceed $1.5 billion.
George Gumpert has been the lead manager of BPSCX since Dec. 29, 2005. Most of the fund's holdings were in companies like Magnite, Inc. (1.9%), Federal Agricultural Mortgage Corp (1.6%) and FirstCash Holdings, Inc. (1.5%) as of Aug. 31, 2025.
BPSCX's 3-year and 5-year annualized returns are 12.4% and 9.5%, respectively. Its net expense ratio is 1.24%. BPSCXhas a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top performing mutual funds, each week.Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
2 Boston Partners Mutual Funds for Solid Returns
Boston Partners, founded in 1995, manages about $127 billion in assets as of Dec. 31, 2025. Its mutual funds cover U.S., global, and non-U.S. equities. The investment strategy employs the three-circle method to choose stocks by evaluating their value, business fundamentals and market trend performance. ESG factors are included in its investment process, making the funds a structured investment option.
We have chosen two Boston Partners mutual funds —Boston Partners Long/Short Equity Inv ((BPLEX - Free Report) ) and Boston Partners Small Cap Value II Inv ((BPSCX - Free Report) ) — that investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Boston Partners Long/Short Equity Inv fund seeks long-term capital appreciation while minimizing exposure to general equity market risk. BPLEX invests in equity securities.
Patrick Regan has been the lead manager of BPLEX since Jan. 1, 2019. Most of the fund's holdings were in companies like Fairfax Financial Holdings Ltd (2.1%), Alphabet Inc. (2%) and British American Tobacco p.l.c. (1.9%) as of Aug. 31, 2025.
BPLEX's 3-year and 5-year annualized returns are 18.5% and 18.5%, respectively. Its net expense ratio is 2.21%. BPLEX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds please click here.
Boston Partners Small Cap Value II Inv fund seeks to provide long-term growth of capital primarily through investment in equity securities. BPSCX invests its net assets in a diversified portfolio consisting primarily of equity securities with market capitalizations that do not exceed $1.5 billion.
George Gumpert has been the lead manager of BPSCX since Dec. 29, 2005. Most of the fund's holdings were in companies like Magnite, Inc. (1.9%), Federal Agricultural Mortgage Corp (1.6%) and FirstCash Holdings, Inc. (1.5%) as of Aug. 31, 2025.
BPSCX's 3-year and 5-year annualized returns are 12.4% and 9.5%, respectively. Its net expense ratio is 1.24%. BPSCX has a Zacks Mutual Fund Rank #2.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top performing mutual funds, each week.Get it free >>